Work

The impact of new drugs for breast and ovarian cancer on the occurrence of therapy-related myeloid neoplasms: Understanding the baseline incidence

Year: 2018

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2018.10.013

Authors: Tal Sella, Richard M. Stone

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Pfizer, Celgene, Agios Pharmaceuticals, Argenx, Astellas Pharma

OpenAlex ID: W2899095922

FWCI: 0.358

Cites: 21

Cited by: 6

Related to: 10